Private company

ANTARES PHARMA, INC.

Last updated Oct 16, 2026.

Overview

  • IndustrySurgical & Medical Instruments & Apparatus
  • HeadquartersDE
  • Incorporated inDE2
  • Business address100 Princeton South, Suite 300, Ewing, Nj 086282
  • Filer categoryLarge accelerated filer2

See how the biggest companies compare on our leaderboards

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2021

35.8%Operating margin3
25.2%Net margin3
23.0%Revenue growth, 20213
26.3%Return on equity3
0.10×Debt to equity3
$30.0MFree cash flow3

Where the money goes

Where each dollar of revenue went, fiscal 2021

  • Research and development8¢$14.5M
  • Selling, general and admin40¢$73.9M
  • Other costs16¢$29.7M
  • Interest2¢$3.6M
  • Income tax9¢$16.0M
  • Profit25¢$46.3M

Out of $184.0M in revenue.3

Where each dollar of operating cash went, fiscal 2021

  • Capital spending18¢$6.6M
  • Kept or used elsewhere82¢$30.0M

Out of $36.6M of cash from operations.3

Financial statements

Revenue45673$184.0M in 2021+303% since 2015
0$50.0M$100.0M$150.0M$200.0M2015: $45.7M$45.7M20152016: $52.2M$52.2M2016+14%2017: $54.5M$54.5M2017+4%2018: $63.6M$63.6M2018+17%2019: $123.9M$123.9M2019+95%2020: $149.6M$149.6M2020+21%2021: $184.0M$184.0M2021+23%
Gross profit456$73.4M in 2019+180% since 2015
0$20.0M$40.0M$60.0M$80.0M2015: $26.2M$26.2M20152016: $23.4M$23.4M2016−11%2017: $27.0M$27.0M2017+16%2018: $32.5M$32.5M2018+20%2019: $73.4M$73.4M2019+126%
Operating income45673$65.9M in 2021
-$25.0M0$25.0M$50.0M$75.0M2015: -$20.5M-$20.5M20152016: -$24.1M-$24.1M2016+18%2017: -$15.6M-$15.6M2017−35%2018: -$4.1M-$4.1M2018−74%2019: $992.0K$992.0K20192020: $13.6M$13.6M2020+1273%2021: $65.9M$65.9M2021+384%
Net income45673$46.3M in 2021
-$25.0M0$25.0M$50.0M$75.0M2015: -$20.7M-$20.7M20152016: -$24.3M-$24.3M2016+18%2017: -$16.7M-$16.7M2017−31%2018: -$6.5M-$6.5M2018−61%2019: -$2.0M-$2.0M2019−69%2020: $56.2M$56.2M20202021: $46.3M$46.3M2021−18%
Fiscal year2015201620172018201920202021
Revenue$45.7M4$52.2M5$54.5M6$63.6M7$123.9M3$149.6M3$184.0M3
Cost of revenue$19.5M4$28.8M4$27.5M4$31.1M6$50.5M6
Gross profit$26.2M4$23.4M5$27.0M6$32.5M6$73.4M6
Research and development$19.7M4$19.6M5$11.9M6$12.3M7$10.6M3$10.1M3$14.5M3
Selling, general and admin$26.9M4$27.9M5$31.6M6$36.8M7$61.8M3$62.8M3$73.9M3
Operating income-$20.5M4-$24.1M5-$15.6M6-$4.1M7$992.0K3$13.6M3$65.9M3
Interest$1.4M6$2.7M7$3.5M3$3.8M3$3.6M3
Income tax$175.0K4$100.0K5$03-$46.3M3$16.0M3
Net income-$20.7M4-$24.3M5-$16.7M6-$6.5M7-$2.0M3$56.2M3$46.3M3
Earnings per share-$0.047-$0.013$0.343$0.273
Earnings per share (diluted)-$0.047-$0.013$0.333$0.263

Compare ANTARES PHARMA, INC. with another company

Former names

  • ANTARES PHARMA INCMay 4, 2005 to May 15, 20082
  • ANTARES PHARMA INCMay 20, 2002 to Jan 10, 20062
  • ANTARES PHARMA INC /MN/Aug 14, 2001 to May 14, 20022
  • MEDI JECT CORP /MN/Aug 21, 1996 to Mar 14, 20012

Recent filings

  1. May 26, 20224 FORM 4 SUBMISSION
  2. May 26, 20224 FORM 4 SUBMISSION
  3. May 26, 20224 FORM 4 SUBMISSION
  4. May 26, 20224 FORM 4 SUBMISSION
  5. May 26, 20224 FORM 4 SUBMISSION
  6. May 26, 20224 FORM 4 SUBMISSION
  7. May 26, 20224 FORM 4 SUBMISSION
  8. May 26, 20224 FORM 4 SUBMISSION
  9. May 26, 20224 FORM 4 SUBMISSION
  10. May 26, 20224 FORM 4 SUBMISSION
  11. May 26, 20224 FORM 4 SUBMISSION
  12. May 24, 20228-K
  13. May 10, 202210-Q
  14. Apr 29, 202210-K/A
  15. Apr 13, 20228-K

Every filing from the last three years, summarized. The full record is on SEC EDGAR.1

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8